Bausch & Lomb (NYSE: BLCO) insider transactions
In the twelve months to 10 November 2026, executives and directors of Bausch & Lomb reported 4 open-market sales of 183,474 shares ($3.5m) and 9 open-market purchases of 69,864 shares ($1.2m), by 10 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 29 October 2026 | Alfonso Eduardo | Director | Grant or award | +1,125 | $20.40 | 32,197 | Form 4 |
| 29 October 2026 | Paulson John | Director | Grant or award | +1,125 | $20.40 | 90,948 | Form 4 |
| 29 October 2026 | Robertson Russel C | Director | Grant or award | +1,256 | $20.40 | 95,516 | Form 4 |
| 29 October 2026 | Munsch Frederick | SVP, Controller and CAO | Option exercise | +24,103 | $17.96 | 69,934 | Form 4 |
| 29 October 2026 | Munsch Frederick | SVP, Controller and CAO | Option exercise | +87,912 | $18.00 | 157,846 | Form 4 |
| 29 October 2026 | Munsch Frederick | SVP, Controller and CAO | Open-market sale | −112,015 | $20.48 | 45,831 | Form 4 |
| 12 August 2026 | Chersi Robert J | Director | Grant or award | +11,776 | — | 11,776 | Form 4 |
| 12 August 2026 | Paul Laurence E | Director | Grant or award | +11,776 | — | 11,776 | Form 4 |
| 12 August 2026 | Trebbi Barbara | Director | Grant or award | +11,776 | — | 11,776 | Form 4 |
| 10 August 2026 | Munsch Frederick | SVP, Controller and CAO | Open-market sale | −52,900 | $16.78 | 45,831 | Form 4 |
| 7 August 2026 | Von Eschenbach Andrew C. | Director | Open-market sale | −6,059 | $16.58 | 63,733 | Form 4 |
| 6 August 2026 | Von Eschenbach Andrew C. | Director | Open-market sale | −12,500 | $16.50 | 69,792 | Form 4 |
| 5 August 2026 | Saunders Brent L | Chairman of the Board and CEO | Shares withheld for tax | −4,231 | $16.76 | 974,158 | Form 4 |
| 5 August 2026 | Saunders Brent L | Chairman of the Board and CEO | Grant or award | +281,879 | — | 1,256,037 | Form 4 |
| 5 August 2026 | Bailey A Robert D | EVP & Chief Legal Officer | Grant or award | +33,557 | — | 264,241 | Form 4 |
| 5 August 2026 | Bonnefoy Luc | President, Surgical | Grant or award | +16,778 | — | 103,801 | Form 4 |
| 5 August 2026 | Eldessouky Sam | EVP and CFO | Grant or award | +50,335 | — | 393,527 | Form 4 |
| 5 August 2026 | Hashad Yehia | EVP of R&D and CMO | Grant or award | +20,973 | — | 187,350 | Form 4 |
| 5 August 2026 | Munsch Frederick | SVP, Controller and CAO | Grant or award | +9,091 | — | 98,731 | Form 4 |
| 5 August 2026 | Stewart Andrew J. | President, GPIC | Grant or award | +16,778 | — | 103,211 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Bausch & Lomb page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.